{
    "id": "0207",
    "question": "A 28-year-old woman returns to the clinic to follow up on a recent abnormal cervical biopsy that demonstrated cervical intraepithelial neoplasia (CIN) I. The patient is quite anxious about the implications of this diagnosis. Her physical examination is within normal limits. Her vital signs do not show any abnormalities at this time. Her past medical, family, and social histories are all non-contributory. Which of the following is the appropriate management of a newly diagnosed CIN I in a 24-year-old patient?",
    "options": {
        "A": "Close observation, pap smear screening at 6 and 12 months, and HPV DNA testing at 12 months",
        "B": "Cryotherapy ablation",
        "C": "Loop electrosurgical excision (LEEP)",
        "D": "Hysterectomy"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To determine the appropriate management for a newly diagnosed CIN I in a 24-year-old patient, we need to consider the current guidelines and recommendations for cervical intraepithelial neoplasia (CIN) management. According to the provided documents, CIN I is a low-grade lesion that requires treatment if colposcopy is unsatisfactory or if the patient is under 21 years old. Since the patient is 24 years old, treatment is recommended regardless of colposcopy findings. The management options for CIN I include cryotherapy ablation, loop electrosurgical excision (LEEP), and close observation with follow-up. However, the most appropriate initial management for CIN I in a young patient is cryotherapy ablation, as it is a less invasive procedure compared to LEEP and has a lower risk of complications. Close observation with follow-up may also be considered, but it is not the most recommended approach for a young patient. Hysterectomy is not indicated for CIN I and is typically reserved for more advanced lesions or as a preventive measure in high-risk patients. Given the patient's age and the low-grade nature of the lesion, cryotherapy ablation is the most appropriate management option.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "Gynecology_Novak_3040",
            "title": "Gynecology_Novak",
            "content": "2. Treatment is recommended for a histologic diagnosis of CIN 3 or if colposcopy is unsatisfactory. Although invasive cervical cancer is very rare in this age group, prospective follow-up of a histological diagnosis of CIN 2 or 3, not otherwise specified, in young women should be limited to those women likely to be compliant with the recommendations. 3. After 2 consecutive negative for intraepithelial lesion or malignancy results, implying negative cytology and colposcopy with satisfactory colposcopic examinations, adolescents and young women can return to routine cytologic screening. An annual screening interval should be recommended. 4. Treatment is recommended if CIN 3 is diagnosed histologically or if CIN 2 or 3 persists for 24 months. 1. Hysterectomy remains the preferred management recommendation for women with a histological diagnosis of AIS on a specimen from a diagnostic excisional procedure (Fig 19.16F). 2."
        },
        {
            "id": "Gynecology_Novak_3029",
            "title": "Gynecology_Novak",
            "content": "All CIN 2 and 3 lesions require treatment in women 21 years of age and older (75). This recommendation is based on a meta-analysis showing that CIN 2 progresses to CIS in 20% of cases and to invasion in 5%. Progression of CIS to invasion is 5% (90). B Management of Women with a Histological Diagnosis of Cervical Intraepithelial Neoplasia Grade 1 (CIN 1) Preceded by HSIL or AGC-NOS Cytology There are 3 Acceptable Options Review of All Findings \u2020 EITHER Observation OR Observation with ^ Except in special populations \u2020 Includes referral cytology, colposcopic fndings, and all biopsies * Provided colposcopy is satisfactory and endocervical sampling is negative. If not, diagnostic excisional procedure. Copyright 2006, 2007, American Society for Colposcopy and Cervical Pathology. All rights reserved. Management of Adolescent Women (20 Years and Younger) with a Histological Diagnosis of Cervical Intraepithelial Neoplasia Grade 1 (CIN 1) Adolescent Women with CIN 1"
        },
        {
            "id": "Gynecology_Novak_3031",
            "title": "Gynecology_Novak",
            "content": "Management of Women with a Histological Diagnosis of Cervical Intraepithelial Neoplasia (CIN 2,3) * Satisfactory Colposcopy Unsatisfactory Colposcopy OR Recurrent CIN 2,3 Either Excision or Diagnostic Excisional Ablation of T-zone * Procedure * * Management options will vary in special circumstances Copyright 2006, 2007, American Society for Colposcopy and Cervical Pathology. All rights reserved. E Management of Adolescent and Young Women with a Histological Diagnosis of Cervical Intraepithelial Neoplasia Grade 2,3 (CIN 2,3) Adolescents and Young Women with CIN 2,3 Either treatment or observation is acceptable, provided colposcopy is satisfactory. When CIN 2 is specifed, observation is preferred. When CIN 3 is specifed, or colposcopy is unsatisfactory, treatment is preferred. @ 6 mos intervals for up to 24 mos OR Ablation of T-zone CIN 3 OR CIN 2,3 Copyright 2006, 2007, American Society for Colposcopy and Cervical Pathology. All rights reserved."
        },
        {
            "id": "Gynecology_Novak_3035",
            "title": "Gynecology_Novak",
            "content": "2. If the HPV DNA test is negative or two consecutive Pap smears are reported as negative, return to routine screening is recommended. 3. If CIN 1 persists for 2 years or more, continued follow-up or treatment is appropriate. Treatment can be ablative or excisional. 4. If colposcopy is unsatisfactory or the endocervical sample is positive for a high-grade CIN, a diagnostic excisional procedure is recommended. 5. Two consecutive negative Pap tests in follow-up of low-grade lesions is not absolute indication that the disease regressed. 1. Women with a histologic diagnosis of CIN 1 diagnosed during the assessment of pap tests showing HSIL (CIN 2 or 3) or atypical glandular cells-not otherwise specified (AGC-NOS) can be managed by either an excisional diagnostic procedure or 6monthly colposcopy and cytology for 1 year (Fig 19.16B). Those with a cytological finding of AGC-NOS must have a satisfactory colposcopic examination and negative endocervical sampling. 2."
        },
        {
            "id": "Gynecology_Novak_3062",
            "title": "Gynecology_Novak",
            "content": "Screening Women with an intact cervix should undergo routine cytologic screening. Because VAIN is nearly always accompanied by CIN, the Pap test result is likely to be positive when VAIN is present. The vagina should be carefully inspected by colposcopic examination at the time of colposcopy for any CIN lesion. Particular attention should be paid to the upper vagina. Women who have persistent abnormal Pap tests without evident cervical pathology and those with abnormal cytology after treatment of CIN should be examined carefully for VAIN. For women in whom the cervix was removed for high-grade cervical neoplasia, Pap testing should be performed at regular intervals (e.g., yearly), depending on the diagnosis and severity of lesion. Figure 19.17 Human papillomavirus (HPV)/vaginal intraepithelial neoplasia grade 1 (VAIN 1). Note the surface spicules with partial uptake of Lugol\u2019s stain."
        },
        {
            "id": "Gynecology_Novak_2960",
            "title": "Gynecology_Novak",
            "content": "The criteria for the diagnosis of intraepithelial neoplasia may vary according to the pathologist, but the significant features are cellular immaturity, cellular disorganization, nuclear abnormality, and increased mitotic activity. The extent of the mitotic activity, immature cellular proliferation, and nuclear atypia identifies the degree of neoplasia. If the presence of mitoses and immature cells is limited to the lower third of the epithelium, the lesion usually is designated as CIN 1. Involvement of the middle and upper thirds is diagnosed as CIN 2 and CIN 3, respectively (Fig. 19.1). Cervical Anatomy The cervix is composed of columnar epithelium, which lines the endocervical canal, and squamous epithelium, which covers the exocervix (5). The point at which they meet is called the squamocolumnar junction (SCJ) (Figs. 19.2 and 19.3). Figure 19.1 Diagram of cervical intraepithelial neoplasia compared with normal epithelium. The Squamocolumnar Junction"
        },
        {
            "id": "Gynecology_Novak_2975",
            "title": "Gynecology_Novak",
            "content": "CHAPTER 19 Intraepithelial Disease of the Cervix, Vagina, and Vulva Figure 19.7 Cervical biopsy showing normal cells, cervical intraepithelial neoplasia 2 and 3 (CIN 2, CIN 3). In CIN 3, the normal maturation is lost. HPV-16 infection is not very specific; it can be found in 16% of women with low-grade lesions and in up to 14% of women with normal cytology. Human papillomavirus type-18 is found in 23% of women with invasive cancers, 5% of women with CIN 2 and CIN 3, 5% of women with HPV and CIN 1, and fewer than 2% of patients with negative findings (18). Therefore, HPV-18 is more specific than HPV-16 for invasive tumors."
        },
        {
            "id": "Gynecology_Novak_3023",
            "title": "Gynecology_Novak",
            "content": "CHAPTER 19 Intraepithelial Disease of the Cervix, Vagina, and Vulva Figure 19.11 A: Mosaic pattern and punctation. This pattern develops as islands of dysplastic epithelium proliferate and push the ends of the superficial blood vessels away, creating a pattern that looks like mosaic tiles. B: Diagram of mosaic pattern. Figure 19.12 Human papillomavirus (HPV)/cervical intraepithelial neoplasia 3 (CIN 3). Cribriform pattern of HPV at periphery with mosaicism and punctation near the squamocolumnar junction. Figure 19.13 Cervical intraepithelial neoplasia grade 3 (CIN 3). CHAPTER 19 Intraepithelial Disease of the Cervix, Vagina, and Vulva Figure 19.14 An algorithm for the evaluation, treatment, and follow-up of an abnormal Pap test. women, and the management of adenocarcinoma in situ led to a critical review of the Guidelines (75,83)."
        },
        {
            "id": "Gynecology_Novak_6888",
            "title": "Gynecology_Novak",
            "content": "Evaluation Vaginal bleeding is the most common symptom occurring in patients with cancer of the cervix. Most often, this is postcoital bleeding, but it may occur as irregular or postmenopausal bleeding. Patients with advanced disease may present with a malodorous vaginal discharge, weight loss, or obstructive uropathy. In asymptomatic women, cervical cancer is most commonly identified through evaluation of abnormal cytologic screening tests. The false-negative rate for Pap tests in the presence of invasive cancer is up to 50%, so a negative Pap test should never be relied on in a symptomatic patient (10). Initially, all women suspected of having cervical cancer should have a general physical examination performed to include evaluation of the supraclavicular, axillary, and inguinofemoral lymph Figure 36.1 Gross appearance of cervical cancer on examination."
        },
        {
            "id": "Pharmacology_Katzung_3731",
            "title": "Pharmacology_Katzung",
            "content": "James L. Zehnder, MD and edema and is tender to touch. Oxygen saturation by fingertip pulse oximeter while breathing room air is 87% (normal > 90%). Ultrasound reveals a deep vein thrombosis in the left lower extremity; chest computed tomography scan confirms the presence of pulmonary emboli. Laboratory blood tests indicate elevated d-dimer levels. What therapy is indicated acutely? What are the long-term therapy options? How long should she be treated? Should this indi-vidual use oral contraceptives? A 25-year-old woman presents to the emergency depart-ment complaining of acute onset of shortness of breath and pleuritic pain. She had been in her usual state of health until 2 days prior when she noted that her left leg was swollen and red. Her only medication was oral contraceptives. Family history was significant for a history of \u201cblood clots\u201d in mul-tiple members of the maternal side of her family. Physical examination demonstrates an anxious woman with stable vital signs. The left"
        },
        {
            "id": "Pharmacology_Katzung_5050",
            "title": "Pharmacology_Katzung",
            "content": "Camille E. Beauduy, PharmD, & Lisa G. Winston, MD motion tenderness is present. A first-catch urine specimen is obtained for chlamydia and gonorrhea nucleic acid amplifi-cation testing. A urine pregnancy test is also ordered as the patient reports she \u201cmissed her last period.\u201d Pending these results, the decision is made to treat her presumptively for chlamydial cervicitis. What are two potential treatment options for her possible chlamydial infection? How does her potential pregnancy affect the treatment decision? A 22-year-old woman presents to her college medical clinic complaining of a 2-week history of vaginal discharge. She denies any fever or abdominal pain but does report vaginal bleeding after sexual intercourse. When questioned about her sexual activity, she reports having vaginal intercourse, at times unprotected, with two men in the last 6 months. A pelvic examination is performed and is positive for muco-purulent discharge from the endocervical canal. No cervical"
        },
        {
            "id": "Gynecology_Novak_3032",
            "title": "Gynecology_Novak",
            "content": "@ 6 mos intervals for up to 24 mos OR Ablation of T-zone CIN 3 OR CIN 2,3 Copyright 2006, 2007, American Society for Colposcopy and Cervical Pathology. All rights reserved. F Management of Women with Adenocarcinoma in-situ (AIS) Diagnosed from a Diagnostic Excisional Procedure * Using a combination of cytology, HPV testing, and colposcopy with endocervical sampling Copyright 2006, 2007, American Society for Colposcopy and Cervical Pathology. All rights reserved. Figure 19.16 (continued) In recognition of the small but real risk for preterm birth, young women less than 20 years may be offered a program of surveillance with cytology and colposcopy at 6-month intervals with treatment only for persistence at 24 months (75). The heterogeneity of CIN 2 lesions is significant and regression rates are higher than for CIN 3. The histological distinction between CIN 2 and CIN 3 remains subjective and these diagnoses are combined in the 2006 Consensus Guidelines."
        },
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "Gynecology_Novak_3019",
            "title": "Gynecology_Novak",
            "content": "Figure 19.8 Colposcopy of cervical intraepithelial neoplasia 2 (CIN 2) associated with human papillomavirus (HPV) infection of the cervix. Punctation Dilated capillaries terminating on the surface appear from the ends as a collection of dots and are referred to as punctation (Fig. 19.9). When these vessels occur in a well-demarcated area of acetowhite epithelium, they indicate an abnormal epithelium\u2014 most often CIN (5) (Fig. 19.10). The punctate vessels are formed as the metaplastic epithelium migrates over the columnar villi. Normally, the capillary regresses; however, when CIN occurs, the capillary persists and appears more prominent. Figure 19.9 Diagram of punctation. The central capillaries of the columnar villi are preserved and produce the punctate vessels on the surface. Figure 19.10 Human papillomavirus (HPV)/cervical intraepithelial neoplasia 2 (CIN 2) presents as a white lesion with surface spicules."
        },
        {
            "id": "Gynecology_Novak_3030",
            "title": "Gynecology_Novak",
            "content": "Management of Adolescent Women (20 Years and Younger) with a Histological Diagnosis of Cervical Intraepithelial Neoplasia Grade 1 (CIN 1) Adolescent Women with CIN 1 Copyright 2006, 2007, American Society for Colposcopy and Cervical Pathology. All rights reserved. Figure 19.16 A\u2013F: Algorithms from the 2006 Consensus Guidelines for the Management of Women with Cervical Histologic Abnormalities. Reprinted from the Journal of Lower Tract Disease, vol. 11, issue 4, with the permission of the ASCCP (c American Society for Colposcopy and Cervical Pathology 2007. No copies of the algorithms may be made without the prior consent of the ASCCP.) Management of Women with a Histological Diagnosis of Cervical Intraepithelial Neoplasia (CIN 2,3) * Satisfactory Colposcopy Unsatisfactory Colposcopy OR Recurrent CIN 2,3"
        },
        {
            "id": "Pharmacology_Katzung_2257",
            "title": "Pharmacology_Katzung",
            "content": "Anthony J. Trevor, PhD not overweight, and she takes no prescription drugs. She drinks decaffeinated coffee but only one cup in the morning; however, she drinks as many as six cans per day of diet cola. She drinks a glass of wine with her evening meal but does not like stronger spirits. What other aspects of this patient\u2019s history would you like to know? What therapeutic measures are appropriate for this patient? What drug, or drugs, (if any) would you prescribe? At her annual physical examination, a 53-year-old middle school teacher complains that she has been having difficulty falling asleep, and after falling asleep, she awakens several times during the night. These episodes now occur almost nightly and are interfering with her ability to teach. She has tried various over-the-counter sleep remedies, but they were of little help and she experienced \u201changover\u201d effects on the day following their use. Her general health is good, she is"
        },
        {
            "id": "Pharmacology_Katzung_5171",
            "title": "Pharmacology_Katzung",
            "content": "A 59-year-old woman presents to an urgent care clinic with a 4-day history of frequent and painful urination. She has had fevers, chills, and flank pain for the past 2 days. Her physician advised her to come immediately to the clinic for evaluation. In the clinic she is febrile (38.5\u00b0C [101.3\u00b0F]) but otherwise stable and states she is not experiencing any nausea or vomiting. Her urine dipstick test is positive for leukocyte esterase. Urinalysis and urine culture are ordered. Her past medical history is significant for three urinary tract infections in the past year. Each episode was uncom-plicated, treated with trimethoprim-sulfamethoxazole, and promptly resolved. She also has osteoporosis for which she takes a daily calcium supplement. The decision is made to treat her with oral antibiotics for a complicated urinary tract infection with close follow-up. Given her history, what would be a reasonable empiric antibiotic choice? Depending on the antibiotic choice are there potential drug"
        },
        {
            "id": "Pharmacology_Katzung_2047",
            "title": "Pharmacology_Katzung",
            "content": "Joshua M. Galanter, MD, & Homer A. Boushey, MD and respirations are 32/min. Her mother states that she has used her albuterol inhaler several times a day for the past 3 days and twice during the previous night. She took an additional two puffs on her way to the emergency department, but her mother states that \u201cthe inhaler didn\u2019t seem to be helping so I told her not to take any more.\u201d What emergency measures are indicated? How should her long-term management be altered? A 14-year-old girl with a history of asthma requiring daily inhaled corticosteroid therapy and allergies to house dust mites, cats, grasses, and ragweed presents to the emergency department in mid-September, reporting a recent \u201ccold\u201d com-plicated by worsening shortness of breath and audible inspi-ratory and expiratory wheezing. She appears frightened and refuses to lie down but is not cyanotic. Her pulse is 120 bpm,"
        },
        {
            "id": "Pharmacology_Katzung_5336",
            "title": "Pharmacology_Katzung",
            "content": "Sharon Safrin, MD A 35-year-old white woman who recently tested seropositive for both HIV and hepatitis B virus surface antigen is referred for evaluation. She is feeling well overall but reports a 25-pack-year smoking history. She drinks 3\u20134 beers per week and has no known medication allergies. She has a history of heroin use and is currently receiving methadone. Physical examination reveals normal vital signs and no abnormalities. White blood cell count is 5800 cells/mm3 with a normal differential, hemoglobin is 11.8 g/dL, all liver tests are within normal limits, CD4 cell count is 278 cells/mm3, and viral load (HIV RNA) is 110,000 copies/mL. What other laboratory tests should be ordered? Which antiretroviral medica-tions would you begin?"
        },
        {
            "id": "InternalMed_Harrison_7879",
            "title": "InternalMed_Harrison",
            "content": "Cervical intraepithelial neoplasia is a slowly progressive lesion and has a low risk of progression to invasive cancer during pregnancy (~0.4%), and many low-grade lesions (36\u201370%) regress spontaneously. Accordingly, some physicians defer definitive diagnostic procedures in pregnant women until 6 weeks postpartum unless they are at high risk for invasive disease. If invasive disease is suspected and the pregnancy is between 16 and 20 weeks, a cone biopsy may be performed to make the diagnosis and may be curative for some lesions; however, the procedure may cause heavy bleeding due to the increased vasculature in the gravid cervix and increases the risk of premature rupture of membranes and preterm labor twoto threefold. Cone biopsy should not be done within 4 weeks of delivery. The only indication for therapy of cervical neoplasia in pregnant women is the documentation of invasive cancer."
        },
        {
            "id": "Biochemistry_Lippincott_1244",
            "title": "Biochemistry_Lippinco",
            "content": "Choose the ONE best answer. For Questions 26.1 and 26.2, use the following scenario. A 40-year-old woman, 5 ft, 1 in (155 cm) tall and weighing 188 lb (85.5 kg), seeks your advice on how to lose weight. Her waist measured 41 in and her hips 39 in. The remainder of the physical examination and the blood laboratory data were all within the normal range. Her only child (who is age 14 years), her sister, and both of her parents are overweight. The patient recalls being overweight throughout her childhood and adolescence. Over the past 15 years, she had been on seven different diets for periods of 2 weeks to 3 months, losing from 5 to 25 lb each time. On discontinuation of the diets, she regained weight, returning to 185\u2013190 lb. 6.1. Calculate and interpret the body mass index for the patient. Body mass index (BMI) = weight in kg/(height in m)2 = 85.5/1.552 = 35.6. Because her BMI is >30, the patient is classified as obese."
        },
        {
            "id": "InternalMed_Harrison_14603",
            "title": "InternalMed_Harrison",
            "content": "follow-up of these patients includes colposcopic examination of the cervix and vagina on a yearly basis. Guidelines from the American College of Gynecology and Obstetrics are available for the treatment of cervical dysplasia and cancer."
        },
        {
            "id": "Pharmacology_Katzung_5664",
            "title": "Pharmacology_Katzung",
            "content": "Philip J. Rosenthal, MD A 5-year-old American girl presents with a 1-week history of intermittent chills, fever, and sweats. She had returned home 2 weeks earlier after leaving the USA for the first time to spend 3 weeks with her grandparents in Nigeria. She received all standard childhood immunizations, but no additional treat-ment before travel, since her parents have returned to their native Nigeria frequently without medical consequences. Three days ago, the child was seen in an outpatient clinic and diagnosed with a viral syndrome. Examination reveals a lethargic child, with a temperature of 39.8\u00b0C (103.6\u00b0F) and splenomegaly. She has no skin rash or lymphadenopathy. Ini-tial laboratory studies are remarkable for hematocrit 29.8%, platelets 45,000/mm3, creatinine 2.5 mg/dL (220 \u03bcmol/L), and mildly elevated bilirubin and transaminases. A blood smear shows ring forms of Plasmodium falciparum at 1.5% parasit-emia. What treatment should be started?"
        },
        {
            "id": "InternalMed_Harrison_7875",
            "title": "InternalMed_Harrison",
            "content": "The incidence of cervical cancer in pregnant women is roughly comparable to that of age-matched controls who are not pregnant. Invasive cervical cancer complicates about 0.45 in 1000 live births, and carcinoma in situ is seen in 1 in 750 pregnancies. About 1% of women diagnosed with cervical cancer are pregnant at the time of diagnosis. Early signs of cervical cancer include vaginal spotting or discharge, pain, and postcoital bleeding, which are also common features of pregnancy. Early visual changes in the cervix related to invasive cancer can be mistaken for cervical decidualization or ectropion (columnar epithelium on the cervix) due to pregnancy. Women diagnosed with cervical cancer during pregnancy report having had symptoms for 4.5 months on average."
        },
        {
            "id": "InternalMed_Harrison_7878",
            "title": "InternalMed_Harrison",
            "content": "of abnormal cytology findings are complex and determined by the degree of abnormality of the cytology finding (e.g., atypical squamous cells of undetermined significance; atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion; low-grade squamous intraepithelial lesion; or high-grade squamous intraepithelial lesion), the HPV status of the patient, the age of the patient, and whether this is the first abnormal finding or a persistent abnormality. A full discussion of all the treatment recommendations based on these factors is beyond the scope of this chapter. Some of the diagnostic procedures recommended for evaluation of nonpregnant women are contraindicated in pregnancy, and the indications for some procedures are modified in the setting of pregnancy. Suffice it to say that the evaluation of women with abnormal cervical cytology in pregnancy should be referred to knowledgeable and experienced gynecologists or gynecologic oncologists."
        },
        {
            "id": "InternalMed_Harrison_7877",
            "title": "InternalMed_Harrison",
            "content": "In 2012, several sets of recommendations were published for screening for cervical cancer: one by the American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP); a second by the U.S. Preventive Services Task Force (USPSTF); and a third by the American College of Obstetricians and Gynecologists (ACOG). Although the details of the recommendations for screening and management of abnormal results differ slightly among the three sets of guidelines, there is general consensus that cytology screening should start at age 21 and continue every 3 years through age 29. After age 30, cytology screening frequency may be reduced to every 5 years if accompanied by co-testing for HPV. Recommendations for management of abnormal cytology findings are complex and determined by the degree of abnormality of the cytology finding (e.g., atypical squamous cells of undetermined significance; atypical squamous cells,"
        },
        {
            "id": "Biochemistry_Lippincott_175",
            "title": "Biochemistry_Lippinco",
            "content": "Choose the ONE best answer. .1. A 30-year-old woman of Northern European ancestry presents with progressive dyspnea (shortness of breath). She denies the use of cigarettes. Family history reveals that her sister also has problems with her lungs. Which one of the following etiologies most likely explains this patient\u2019s pulmonary symptoms? A. Deficiency in dietary vitamin C B. Deficiency of \u03b11-antitrypsin C. Deficiency of prolyl hydroxylase D. Decreased elastase activity E. Increased collagenase activity"
        },
        {
            "id": "Biochemistry_Lippincott_1848",
            "title": "Biochemistry_Lippinco",
            "content": "TQ5. A.Why are triacylglycerols and cholesterol elevated? Hint: Glucose is the primary carbon source for their synthesis. B.Why are ketone bodies not elevated? Case 3: Hyperglycemia and Hyperketonemia Patient Presentation: MW, a 40-year-old woman, was brought to the hospital in a disoriented, confused state by her husband. Focused History: As noted on her medical alert bracelet, MW has had type 1 diabetes (T1D) for the last 24 years. Her husband reports that this is her first medical emergency in 2 years. Physical Examination (Pertinent Findings): MW displayed signs of dehydration (such as dry mucous membranes and skin, poor skin turgor, and low blood pressure) and acidosis (such as deep, rapid breathing [Kussmaul respiration]). Her breath had a faintly fruity odor. Her temperature was normal."
        },
        {
            "id": "Gynecology_Novak_3005",
            "title": "Gynecology_Novak",
            "content": "The American College of Obstetricians and Gynecologists (ACOG) updated its guidelines (62). The ACOG recommends that women not initiate cervical cancer screening until they are 21, regardless of the onset of sexual activity. This acknowledges the very low prevalence of invasive cancer in very young women, the long multiyear process of cervical carcinogenesis, and the very low but real risks for preterm birth associated with outpatient excisional procedures. Likewise screening frequency was revised to every 2 years from age 21 to 29 (with either conventional slide or liquid-based cytology), and every 3 years for women after age 30 years if three consecutive negative, i.e., negative for intraepithelial lesion or malignancy (NILM) Pap tests can be documented. More frequent screening continues to be recommended for HIV-positive women (twice first year and annually after), those who are immune-suppressed, diethylstilbestrol (DES) daughters, and for those with a history of CIN 2 or greater"
        },
        {
            "id": "Pharmacology_Katzung_1897",
            "title": "Pharmacology_Katzung",
            "content": "The Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, & Related Compounds John Hwa, MD, PhD, & Kathleen Martin, PhD* pulmonary pressures, and right ventricular enlargement. Cardiac catheterization confirmed the severely elevated pulmonary pressures. She was commenced on appropri-ate therapies. Which of the eicosanoid agonists have been demonstrated to reduce both morbidity and mortality in patients with such a diagnosis? What are the modes of action? A 40-year-old woman presented to her doctor with a 6-month history of increasing shortness of breath. This was associated with poor appetite and ankle swell-ing. On physical examination, she had elevated jugular venous distention, a soft tricuspid regurgitation murmur, clear lungs, and mild peripheral edema. An echocardio-gram revealed tricuspid regurgitation, severely elevated"
        },
        {
            "id": "Obstentrics_Williams_8620",
            "title": "Obstentrics_Williams",
            "content": "Pregnancy provides an opportune time to screen for cervical intraepithelial neoplasia (CIN), especially in women without regular access to health care. With Pap test screening, preg nancy status is noted on the requisition form because interpre changes. Some of these changes include presence of decidual cells and less often, Arias-Stella reaction. he latter gives an appearance of endocervical gland hyperplasia, which can make diferentiating this from truly atypical glandular cells diicult."
        },
        {
            "id": "Pathoma_Husain_338",
            "title": "Pathoma_Husain",
            "content": "Progression from CIN to carcinoma, on average, takes 10-20 years. 2. Screening begins at age 21 and is initially performed every three years. B. Pap smear is the gold standard for screening. 1. Cells are scraped from the transformation zone using a brush and analyzed under a microscope. 2. Dysplastic cells are classified as low grade (CIN I) or high grade (CIN II and III). 3. High-grade dysplasia is characterized by cells with hyperchromatic (dark) nuclei and high nuclear to cytoplasmic ratios (Fig. 13.4C). C. Pap smear is the most successful screening test developed to date. Fig. 13.4 Cervix. A, Cervical transformation zone, normal. B, CIN Ill. C, High-grade dysplasia, Pap smear. (Courtesy of Ed Uthman, MD) 1. It is responsible for a significant reduction in the morbidity and mortality of cervical carcinoma (cervical carcinoma went from being the most common to one of the least common types of gynecologic carcinoma in the US). 2."
        }
    ],
    "scores": [
        0.035114778539638486,
        0.033043869559900116,
        0.03185727018079959,
        0.02753313310001114,
        0.02688869579981112,
        0.024005291968035906,
        0.023375292740046835,
        0.023270339363533194,
        0.02162369009772754,
        0.0196078431372549,
        0.019424799622819428,
        0.019344465058750773,
        0.019246784491533265,
        0.018965006443712566,
        0.017869964100518547,
        0.01752123786407767,
        0.017475875693336373,
        0.017273471818926363,
        0.016877937615724255,
        0.016680339075745145,
        0.01611899427433408,
        0.01610889110889111,
        0.016018306636155607,
        0.01581493425948896,
        0.015639980824544583,
        0.01562592482983131,
        0.015592203898050975,
        0.015548567435359888,
        0.015518796992481203,
        0.015425531914893617,
        0.015376458112407211,
        0.015339578454332554
    ]
}